Transfusion-Transmitted Virus

New virus may be prognostic marker for chronic hepatitis C-related liver cancer

Published in Hepatitis Weekly, September 9th, 2002

by Sonia Nichols, senior medical writer - TT virus, also known as transfusion transmitted virus, may be a marker for cancer progression in people with chronic hepatitis C-related liver disease.

TT virus (TTV) was discovered only a few years ago. Despite growing evidence that suggests TTV is fairly common among individuals with and without liver disease, a new report by medical researchers at Jichi Medical School in Japan indicates TTV may predict the risk for hepatocellular carcinoma, a primary form of liver cancer, in those with chronic hepatitis C. Its effect on cancer progression in those individuals remains unknown.

The investigators used...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2002-09-09)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry